Use of new technologies for the management of glycemia in patients with various carbohydrate metabolism disorders during pregnancy

It has been established that during pregnancy women may develop physiological resistance to the action of insulin, which in itself is a risk factor for carbohydrate metabolism disorders. Early diagnosis of hyperglycemia in women at risk for diabetes at the beginning of pregnancy and in women with diagnosed diabetes before pregnancy at the planning stage may prevent pregnancy and childbirth complications. Self-monitoring of blood glucose for such patients is an integral part of the guidelines on follow-up of such women. The achievement of normoglycemia throughout the gestation period makes it possible to forecast perinatal outcomes such as reduced rates of development of macrosomia, severe degrees of diabetic fetopathy, and an increased rates of natural births. The use of modern technologies for the management of glycemia during pregnancy, namely portable glucometers for daily monitoring of blood glucose, determines the choice of therapy for women with various carbohydrate metabolism disorders during pregnancy.

1. International Diabetes Federation IDF Diabetes Atlas, 8th edn.: International Diabetes Federation, 2017. http://www.diabetesatlas.org/resources/2017-atlas.html.

2. HAPO Study Cooperative Ressearch Group. The hyperglycemia and advese pregnancy outcome (HAPO) study. Int J. Gynaecol Obstat, 2002 Jul, 78(1): 69-72.

3. http://www.comtecmed.com/DIP/2017/uploads/editor/European%20HIP%20Declaration_February%202017.pdf

4. Hod M, Kapur A, Sacks DA et al. The international Federation of Gynecology and Obstetrios (FIGO) initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet, 2015 Oct, 131 (Suppl 3): S173-211. doi: 10.1016/S00207292(15)30007-2.

5. Kumar AS, Srivastava VK, Sood B. Public Healt, Jhpiego, India: Demonstrating effectiveness of an antenatal care (ANC) based gesnational diabetes mellitus (GDM) screening in Madhya Pradesh, Indi. E–Posters abstracts. DIP march 8-12, 2017, Barcelona, Spain.

6. Lincetto O, Monthebesoane-Anoh S, Gomez P, Munjanja S. Antenatal care (ANC) Opportunities for Africas Newborns. 2013: 51-52.

7. International Organization for Standardization: in vitro diagnostic test systems-requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2013.

8. Food and Drug Administration: Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use-Guidance for Industry and Food and DrugAdministrationStaff. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm380327.pdf (accessed October 10, 2016).

9. /Dedov II, Krasnopolsky VI, Sukhikh GT. on behalf of the working group: Russian national consensus «Gestational diabetes mellitus: diagnosis, treatment, postpartum follow-up». Sakharnyy diabet. Normativnye dokumenty, 2012, 4: 4-10.

10. Savelyeva LV. Endocrinology. National guidelines. Edited by Dedova II, Melnichenko GA. Moscow: GEOTARMedia, 2013: 585-559.

11. Dreval AV, Shestakova TP, Bunak IV. Gestational diabetes mellitus (based on the screening study of the Moscow region). doi: http://dx.doi.org/10.18786/2072-0505-2016-44-4-406-413.

12. Dedov II, Shestakova MV. Clinical guidelines, 8th issue, Standards of Specialized Diabetes Care, 2017, 20 (1S): 1-112. doi: 10.14341 / DM20171S8.

13. American Diabetes Association (ADA) Standards of medical are in diabetes – 2017. Diabetes Care, 2017, 40(suppl): s48-s56.

14. Grigoryan OR, Sheremetyeva EV, Andreeva EN. Diabetes mellitus and pregnancy: a scientific and practical guide. Edited by Dedov II, Grigoryan ОР. M: Vidar-M, 2011. 146 p.

15. American Diabetes Association (ADA) Standards of medical are in diabetes 2017. Diabetes Care, 2017, 40 (suppl): 18-19.

16. Bolotskaya LL, Bessmertnaya EG, Shestakova MV, Shamkhalova MSh, Nikankina LV, Ilyin AV, Glek IS, Zolotukhin AV, Dedov II. A prospective 20-year follow-up study assessing the development of retinopathy and nephropathy from the onset of type 1 diabetes mellitus: the contribution of glycaemia management and “metabolic memory”. Terapevticheskiy Arkhiv, 2017, 10: 17-21.

17. Diabetes Prevention Program Research Group. HbA1c as a predictor of diabetes andas an outcome in the diabetes prevention program: a randomized clinical trial. Diabetes Care, 2015, 38: 51-58.

18. Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and PregnancyStudy Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosisand classification of hyperglycemia in pregnancy. Diabetes Care, 2010, 33: 676-682.

19. Freckmann G, Link M, Schmid C et al. System accuracy evaluation of different blood glucose monitoring systems following ISO 15197:2013 by using two different comparison methods. Diabetes Technol Ther, 2015, 17: 635-648.

20. Duran A, Sáenz S, Torrejón MJ et al. Introductionof IADPSG criteria for the screening anddiagnosis of gestational diabetes mellitus resultsin improved pregnancy outcomes at alower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care, 2014, 37: 2442-2450.

21. Contour Plus One. Руководство пользователя (Рег. удостоверение № ФСЗ 2008/02237 от 30.05.2017).

22. Dunne N et al. Accuracy Evaluation of Contour Plus Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther, 2015 Sep 14, 6(3): 377-388. Epub 2015 Jul 14.